Back to top

EyePoint reports Q2 EPS ($1.09), consensus (96c)

Reports Q2 revenue $507,000, consensus $372,290. “With topline data from our pivotal Phase 3 LUGANO wet AMD trial expected this month, followed by ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

EyePoint, Inc. (EYPT)